Back to UBS Group AG UBS Group AG

ALZNALZN
5 quarters

Position history for UBS Group AGUBS Group AG's holdings in ALZAMEND NEURO INC

UBS Group AG holds 2,352 shares of ALZN (ALZAMEND NEURO INC), worth $2,822 as of 2026-Q2. The position was decreased (-47.8% shares).

Current Value

$2,822

Current Shares

2,352

Total Value Change

+$197

Total Shares Change

+1,450

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Decreased
2,352
-47.8%
$2,8220.0%$1.20
0
2026-Q1
Decreased
4,504
-81.7%
$4,7740.0%$1.88
0
2025-Q4
Increased
24,567
+1084.0%
$44,7120.0%$1.92
22
2025-Q3
Increased
2,075
+130.0%
$4,9390.0%$2.36
16
2025-Q2
New
902
-
$2,6250.0%$2.90
19

Other major holders of ALZN: VANGUARD GROUP INC, GEODE CAPITAL MANAGEMENT, LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used